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Abstract 
Background: Cost-benefit evaluation of measures against respiratory disease in cattle requires accounting with 
the associated production losses. Investigations of naturally occurring respiratory infections in a herd setting are an 
opportunity for accurate estimates of the consequences. This article presents estimates based on individual monitor-
ing of weight and concentrate intake of several hundred bulls previous to, during and after a respiratory infection 
outbreak with bovine respiratory syncytial virus (BRSV) as the main pathogen. The aim of the study was to analyse the 
association between exposure to BRSV, weight gain and feed conversion rate, quantify any change in these param-
eters, and estimate the duration of the change in production.
Results: A comparison of growth curves for the bulls that were present during the outbreak revealed that bulls 
with severe clinical signs had a clear and consistent trend of poorer growth rate than those with milder or no signs. 
The weight/age-ratio was 0.04–0.10 lower in the severely affected bulls, and evident throughout the study period of 
8 months. A comparison of growth rates between apparently healthy bulls being present during the outbreak and a 
comparable group of bulls exactly 1 year later (n = 377) showed a reduced growth rate of 111 g/day in the first group. 
The difference amounted to 23 extra days needed to reach the reference weight. Feed conversion was also reduced 
by 79 g weight gain/kilogram concentrate consumed in the outbreak year.
Conclusion: This study indicates significant negative effects on performance of animals that develop severe clini-
cal signs in the acute stage, and that the growth and production is negatively affected many months after apparent 
recovery. In addition, the performance of apparently healthy animals that are exposed during an outbreak are severely 
negatively affected. The duration of this decrease in production in animals after recovery, or animals that have not 
shown disease at all, has not previously been documented. These losses will easily be underestimated, but contribute 
significantly to the costs for the producer. The findings emphasize the importance of BRSV infection for profitability 
and animal welfare in cattle husbandry. The study also illustrates that utilising intra-herd comparison of health and 
production parameters is a productive approach to estimate consequences of an outbreak.
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Background
Bovine respiratory disease is amongst the most signifi-
cant causes of health problems and reduced welfare and 
profitability in the cattle industry. Decreases in production 
and profitability are associated with factors such as reduced 
growth rate, treatment costs and increased mortality. In 
dairy herds, one may also observe reduced milk produc-
tion, milk quality and reproductive performance [1–5].
Bovine respiratory syncytial virus (BRSV) is an impor-
tant etiological agent in bovine respiratory disease [6]. 
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The infection can be subclinical, or result in mild to 
severe clinical signs. Disease might be caused by BRSV 
directly or in combination with secondary bacterial infec-
tions which occurs frequently [7, 8]. The morbidity in a 
BRSV outbreak is reported to be between 60 and 80  %, 
and the mortality between 0 and 20 % [6].
Many experimental studies have been conducted to 
describe the clinical and pathological consequences of 
BRSV infection [7, 9–13]. However, experimental infec-
tion usually results in less severe disease compared to 
natural outbreaks, fewer animals are usually included, 
and the animals are monitored for a relatively short 
period after virus exposure. Studies on natural BRSV out-
breaks [14–19] often lack relevant information on the sit-
uation prior to the outbreak, and suitable control groups 
are usually not available. Furthermore, such studies often 
provide little information on the production after the 
outbreak.
Large scale epidemiological studies from data records 
investigating production losses and economic impact of 
bovine respiratory disease are usually based on clinical 
diagnosis, without specific information about the etio-
logical agent [1, 2, 4]. For BRSV specifically, reduced milk 
yield [5, 20] and reduced semen quality [21] are amongst 
the reported effects. Studies on negative consequences 
of this infection, relevant for rearing of young stock, are 
scarce and represent an important knowledge gap in the 
estimation of the total consequences of BRSV.
The Norwegian cattle population is currently free from 
several globally important respiratory pathogens such 
as bovine herpes virus type 1 [22] and bovine viral diar-
rhoea virus [23], and Mycoplasma bovis has never been 
detected [24]. This makes the Norwegian cattle popu-
lation a suitable population for studying the impact of 
BRSV. The prevalence on herd level is estimated to be 
between 34 and 41 % [25]. BRSV has been found to be the 
main cause of outbreaks of respiratory disease, either act-
ing as a single agent or in combination with other patho-
gens. Other viral pathogens known to cause respiratory 
disease in Norwegian cattle, are bovine corona virus 
(BCoV) and bovine parainfluenza virus type 3 (BPIV3) 
[26].
To calculate the cost-efficiency of preventive strate-
gies for BRSV, accurate estimates of the potential losses 
are essential. The aim of the present study was to provide 
robust estimates of such losses by analysing the associa-
tion between exposure to BRSV, weight gain and feed 
conversion rate, quantify any reduction in these param-
eters, and estimate the duration of decreased production. 
Furthermore, it was an objective to illustrate a method 
for estimating the effect of disease outbreaks in beef 
herds by employing intra-herd comparisons based on 
health and production records.
Methods
The research herd belonged to an artificial insemination 
test centre housing up to 330 Norwegian Red bulls under 
standardized conditions enabling registration of a num-
ber of phenotypic traits including weight gain and body 
conformation. Five times throughout the year, new bulls 
enter the test centre. At arrival, they are about 3 months 
old and they stay until a maximum age of 13  months. 
The bulls’ age at arrival is similar to what is common in 
conventional Norwegian rearing units. The bulls’ health 
is closely monitored by the resident veterinary surgeons. 
The centre has loose housing pens holding 15–25 ani-
mals. The animals are grouped in pens according to their 
age. There are computer‒controlled concentrate feeders 
dispensing a concentrate formula containing 13.6 % pro-
tein and 6624  kJ per kg (Formel Favør 90, Felleskjøpet 
Agri, Norway). The allotment starts at 2500 g per day, and 
reaches a maximum of 4000 g at the age of 210 days. The 
concentrate consumption and body weight of the animal 
are recorded each time it enters the feeder. Grass silage is 
supplied ad libitum. The daily weight gain of the bulls in 
the centre is normally 1300–1400 g per day between 150 
and 330 days of age.
Starting on 24 January 2011, clinical signs of respira-
tory disease were observed in the herd. During the out-
break period, approximately three quarters of the bulls 
showed clinical signs of respiratory disease to some 
degree. At the time of the outbreak, isolation of the sick 
animals was not possible. The clinical signs of disease 
ranged from nasal and ocular discharge, coughing, polyp-
nea (respiratory rate ≥60 movements/minute), fever, 
depression and anorexia to grunting with open mouth 
breathing and froth, stretched neck and death. Those 
showing decreased uptake of concentrate, weight loss, 
depression and strained respiration were given a stand-
ard treatment of 2 days of meloxicam injections and five 
daily injections of procaine penicillin to prevent second-
ary bacterial infections. Of the 265 bulls present at the 
onset of the outbreak, 14 (5.3  %) either died or had to 
be euthanized because of severe respiratory distress. At 
the time of the outbreak, about half of the bulls had been 
vaccinated with a respiratory pathogen vaccine including 
BRSV (Bovilis Bovipast RSP vet).
Diagnostic sampling
Serum, nasal swabs and broncheoalveolar lavage (BAL) 
samples were collected from seven animals in the early 
phase of the disease, 2  days after the onset of the out-
break. Two weeks later, a second serum sample was col-
lected from each of the animals except one that had died. 
The age at the first sampling was on average 143 days.
An indirect ELISA detecting serum antibodies to BRSV, 
BPIV3 and BCoV (SVANOVIR® BRSV-Ab, PIV3-Ab and 
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BCV-Ab, Svanova Biotech AB, Uppsala, Sweden) was 
used, following the manufacturer’s instructions. In brief, 
the optical density (OD) reading of 450 nm was corrected 
by the subtraction of OD for the negative control antigen, 
and percent positivity (PP) was calculated as (corrected 
OD/positive control corrected OD) × 100. A sample was 
considered positive for antibodies if PP ≥ 10 and negative 
if PP < 10. The animals were regarded as acutely infected 
with BRSV, BCoV or BPIV3 if the animals seroconverted, 
i.e. if the first sample was negative and the second sample 
was positive or if they had a strong increase in antibodies, 
i.e. if the PP increased at least 70 %.
Real time polymerase chain reaction (RTqPCR) for 
detection of the N-protein of BRSV in the nasal swabs 
and BAL samples was performed as previously described 
by Klem et al. [26].
Five of the six bulls with paired serum samples either 
seroconverted (four) or had a strong increase in BRSV 
antibody level in percent positivity of at least 70 % (one). 
Two of the six bulls seroconverted for BCoV and two of 
them had a strong increase in antibody level for BPIV3. 
The seven animals tested were positive for BRSV on nasal 
swabs (five) and/or BAL samples (seven) by RTqPCR 
(Table 1).
Post-mortem examinations were performed on four 
euthanized animals. Before euthanasia, the animals were 
in the terminal face of respiratory disease with anorexia, 
grunting with open mouth breathing, froth and stretched 
neck. Gross pathological and histological findings were 
recorded. For the histological investigation, sections of 
the lung tissue were stained with haematoxylin-eosin. 
Immunohistochemistry (IHC) was accomplished by 
use of a cryostat on frozen sections of lung tissue with 
anti-BRSV isotype IgG1 kappa (Nordic BioSite, Sweden) 
at a dilution of 1:100. In brief, the section was fixed in 
10  % buffered formalin for 2  min followed by 2  min in 
70 % alcohol. Inhibition was carried out with 0.05 % phe-
nyl hydrazine in phosphate buffered saline at 37  °C for 
40  min. The blocking was accomplished with N-serum 
from goat 1:50 in a solution of 5  % bovine serum albu-
min in tris-buffered saline for 20 min. Primary antibodies 
were diluted in 1  % bovine serum albumin in tris-buff-
ered saline and incubated for 1 hour at room temperature 
(around 21  °C). The secondary antigen (Labelled poly-
mer, HRP anti mouse) was incubated for 30 min before 
developing with 3-amino-9-ethylcarbazole for 20  min 
and counterstained with haematoxylin for 30 s. Sections 
stained by IHC were examined microscopically to deter-
mine the types of cells labelled for viral antigen. Lung tis-
sue from all four animals examined for the presence of 
BRSV antigen with IHC was positive.
All the examined animals had a bronchointersti-
tial pneumonia characteristic of a BRSV-infection: the 
cranioventral parts of the lungs were consolidated and 
mucopurulent exudate was observed in the bronchus and 
small bronchi. The caudodorsal parts of the lungs were 
distended. There was emphysema, especially in the bor-
der between the consolidated cranioventral parts of the 
lung and the more normal caudodorsal parts. The trache-
obronchial and mediastinal lymph nodes were markedly 
enlarged with a mottled cut surface. Microscopic lesions 
consisted of necrosis of the epithelium in the bronchi-
oli and alveoli with rejection of epithelia to the lumen. 
Infiltration of neutrophil granulocytes and macrophages 
was also present in the lumen. There was hypermia and 
haemorrhage from capillaries into the bronchioli and 
alveoli. In the bronchioli, syncytial cells typical of the 
paramyxovirus were formed by fusion of epithelial cells 
and in the wall of the alveoli hyaline membranes were 
present.
By culturing of lung tissue from the four autopsied 
calves, Mannheimia haemolytica was identified in one, 
Pasteurella spp. in the second, and in the two remaining, 
no bacteria were detected.
Based on the antibody detection of paired serum sam-
ples from the six bulls, BRSV detection by PCR of the 
same animals, post mortem examination of four other 
animals and detection of BRSV by IHC of lung tissue 
from these four, the conclusion was that BRSV was the 
principal pathogen involved.
Data analysis
Daily data on allotted concentrate and consumption, 
as well as body weight, were available for a total of 816 
bulls being monitored during 2011 and/or 2012. The 
sum of registrations resulted in a data set of more than 
Table 1 Results of the serological and virological testings
The serological results are based on detection of antibodies in paired serum 
samples. Animals were defined as positive for infection if they seroconverted 
(negative to positive) or if the antibody titer increased ≥70 %
BRSV bovine respiratory syncytial virus, BCoV bovine corona virus. BPIV3 bovine 
parainfluenza virus type 3, + positive for infection, − negative for infection, N/A 
not applicable, TA transtracheal aspirate, BAL broncheoalveolar lavage
Serology, paired serum samples Virology 
BRSV
Bull no. BRSV BCoV BPIV3 TA BAL
1 − + − − +
2 + + + − +
3 + − − + +
4 + − + + +
5 + − − + +
6 + − − + +
7 N/A N/A N/A + +
Total no. of pos. 5/6 2/6 2/6 5/7 7/7
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150.000 days of bull observations. There was a consider-
able frequency of missing data in the set, so that statistics 
relating to a variable’s value on a specific date may not 
have included every individual in the herd at that time. 
Standardization of the raw data associated with the anal-
yses in some instances further reduced the effective num-
ber of observations. Thus, the N figures given for analyses 
are generally lower than the nominal number of bulls.
Two different comparisons were made.
1. The performance of the bulls classified as sick (i.e. 
medically treated) was compared to that of the 
exposed, but not sick. This was to test the correlation 
between short-term clinical consequences and long-
term performance.
2. The exposed, but not medically treated bulls were 
compared with non-exposed bulls (outbreak year 
versus next year). The aim of this comparison was to 
detect an eventual effect on the performance of those 
exposed but not deemed to be sick.
Adjustments to the data set were necessary for sta-
tistical analyses and meaningful comparison of graphs, 
the main concern being the presence of age bias. For 
instance, the bulls getting medical treatment were on 
average much younger than the untreated group. To 
provide comparable groups for analyses involving body 
weight of the medically treated and untreated groups, 
the older bulls were excluded by adjusting the earliest 
included birth date downwards while watching the age 
distribution graphs of the two groups in the graph builder 
window of the statistical software. Specifically, the graphs 
became acceptably congruent when the bulls born after 
June 1 2010, i.e. younger than 230  days by January 24, 
2011, remained. A plot showing the age distribution 
after this procedure is presented in Fig. 1. The procedure 
resulted in a reduction of the N value corresponding to 
any given day so that it led to a reduction from a maxi-
mum of 220 bulls to 143. Most of the reduction was obvi-
ously associated with the untreated group as they were of 
higher age. The dip in the age graphs, i.e. drop in aver-
age herd age, just before the outbreak is caused by a large 
cohort of young bulls being introduced at once.
To further enable comparisons of weights on the same 
day of animals that would not be of the same age, an age 
adjusted weight variable (AAW) was created by divid-
ing an animal’s weight in kilograms by its age in days. 
Furthermore, two breakdown variables were created: 
An average daily weight gain variable (ADG) was cal-
culated by dividing the total weight gain, i.e. the differ-
ence between the bull’s maximum and minimum body 
weight, by the number of days it had been housed in the 
centre. Secondly, a variable of the total feed conversion 
ratio (FCR) for each bull was created by dividing the total 
amount of concentrate consumed over the total monitor-
ing time, by the total weight gain during the same period. 
Furthermore, in the analysis of the performance break-
down variables, ADG and FCR values based on bulls with 
more than 5  % missing values were deemed unreliable 
and excluded from statistical analysis, reducing the nom-
inal set of bulls from 792 to 463.
The peak exposure period was defined from 2  weeks 
prior to and 4 weeks after the clinical onset i.e. January 
10–February 4. By studying the individual weight gain 
curves it was possible to identify drops in body weight 
within this period. Each bull’s most notable drop in 
body weight during the 6  weeks of the highest disease 
incidence was identified. The lowest body weight in this 
drop, the highest preceding weight, the corresponding 
dates, and the number of days until that weight had been 
regained, were recorded as analysis variables.
Comparisons of group means of continuous variables 
were carried out employing the two-tailed t test. Inves-
tigation of associations between dichotomous variables 
was calculated by Fisher’s exact test (two-tailed). The sta-
tistics and analyses were performed using JMP 10 com-
puter software (SAS Institute, Cary, NC, USA).
Results
Sick versus not sick bulls (present during outbreak)
Medical treatment was initiated in 56 bulls (21  %). The 
medically treated animals were younger than the others, 
their mean age at the start of the outbreak being 156 days 
compared to 255 days (P < 0.05).
The investigation of the role vaccination may have 
played showed that being vaccinated was highly con-
founded with higher age, with the vaccinated bulls being 
on average 27  days older than the others, and the bias 
was also reflected among the sick versus not sick group, 
the latter group being 81  days older. The bias was too 
pronounced to allow for control of the factor in analyses 
so that further quantification of vaccination effect did not 
provide meaningful results.
A drop in body weight was seen in the majority of ani-
mals in the outbreak period. This was more pronounced 
in the group of the medically treated bulls (P < 0.05), who 
lost 6 % of their initial body weight while the rest had a 
mean drop of 3  %. Furthermore, the medically treated 
bulls spent a significantly (P < 0.05) longer period in the 
decrease from maximum to minimum weight (5.0 days) 
than the untreated (3.1 days). Figure 2 shows the distri-
bution of animals according to weight loss.
The medically treated and untreated bulls consumed 
the same amount of concentrate (as  % daily ration), dur-
ing the peak infection period, the maximum difference 
being only 0.26 percentage points.
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A plot of the two groups’ AAW over time revealed a 
consistent difference in disfavour of the medically treated 
bulls. The difference developed quickly around the peak 
outbreak date, the 24 January 2011, reaching its maxi-
mum just after. The trend was evident from the date of 
the outbreak and was then visible for several months 
(Fig.  3). Statistical analyses of AAW on selected dates 
confirmed the trend and provided estimates of the differ-
ence in AAW of 0.04–0.10 (Table 2).
Exposed versus non‑exposed bulls (year versus year 
comparison)
The general disease incidence numbers per year showed 
a clear difference in the incidence of respiratory disease 
between the outbreak year and control year (Table 3).
The plot of mean AAW over time, comparing 2011–
2012 date by date (Fig. 4), showed that the AAW of 2011 
started higher, then fell to a lower level and stayed below 
the control year level for many months. When the groups 
were compared with respect to average FCR as well as 
ADG, the 2011 group had poorer figures (Table 4).
Discussion
Even though there were indications of other respiratory 
pathogens present in the herd, it is highly likely that BRSV 
was the main cause of the outbreak. Firstly, the clinical 
signs and the high number of cases in a short period of 
time indicate a highly virulent infectious agent being the 
likely cause of the outbreak investigated in the present 
study. Serological examination did indicate BRSV infec-
tion in most animals. Even if increasing antibody levels 
to BCoV and BPIV3 were also detected, the increase was 
Fig. 1 Similar age composition over time in two groups of bulls. The two graphs show similar curve shapes after excluding bulls born before a 
certain date (June 1, 2011) from data set. About 80 bulls were removed from a set of 220 bulls
0
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Fig. 2 Distribution of degree of maximum drop in bulls’ individual 
body weight during bovine respiratory outbreak. Reduction in per-
cent of body weight, corresponding to proportion of bulls. N = 225
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present in a lower number of animals. In addition, BRSV 
was detected by RTqPCR. Furthermore it is reported that 
BPIV3 acting as a single agent mainly causes mild dis-
ease, and even when coinciding with BRSV infection it 
does not change the clinical signs significantly [27, 28]. 
Similarly, respiratory BCoV infections usually cause mild 
disease in infected calves [29]. Infection with BRSV pre-
dispose to infection with opportunistic bacteria [7], and 
it has been reported that 40 % of the viral infections lead 
to secondary bacterial infections [8]. In Norway, Pasteur-
ella multocida and Trueperella pyogenes are the two most 
common bacteria causing secondary infections. Mannhe-
imia haemolytica are also relatively commonly detected 
and Histophilus somni appears to be rare [30, 31]. Pri-
mary pulmonary pasteurellosis is generally uncommon 
in beef or dairy cattle in Norway, and it has never been 
diagnosed in the centre described in the present study. 
The severity and character of the outbreak indicated a 
secondary origin of the bacteria cultured from lung tis-
sue. BRSV as the principal pathogen in the outbreak is 
also supported by the detection of pathological lesions 
typical for BRSV infection and the IHC with positive 
staining of BRS viral antigen. The losses connected with 
the outbreak may be due to either primary effect of the 
virus and/or secondary bacterial infections.
Fig. 3 Weight to age ratio in two groups of bulls present during outbreak. Bulls that were diagnosed and treated for respiratory disease versus 
those without diagnosis and treatment. The figure shows the ratio in relation to the outbreak date 24 January 2011
Table 2 Age adjusted body weights in sick bulls versus not 
sick bulls following  respiratory disease outbreak January 
24th
** P < 0.05
a The figure varies from day to day because of occurrence of missing values 
from the automated weighing
Date (days after onset  
of outbreak)
Feb. 1 (7) Mar. 25 (60) May 25 (120)
Na 106 143 138
Not treated (n) 1.14 (64) 1.18 (85) 1.19 (82)
Medically treated (n) 1.04 (42) 1.12 (58) 1.15 (56)
Difference 0.10** 0.06 0.04
Table 3 General health status of  bulls in  outbreak year 
versus control year
Year 2011 2012
Animals at risk 543 516
Drug treatment for respiratory disease 64 26
Drug treatment for other disease 93 96
Euthanasia/death from respiratory disease 14 0
Euthanasia/death from other disease 0 0
Emergency slaughter 1 7
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At first, the analysis of vaccination status seemed to 
indicate a protective effect of vaccination. However, 
because the age distribution between the two groups 
with respect to experiment variable as well as outcome 
variable (medical treatment) was highly unequal, it is 
not possible to draw this kind of conclusion. Higher age 
would be associated with, i.e., generally stronger phy-
sique, more acquired immunity from factors outside of 
vaccination, and more time for the vaccine to have pro-
duced any effect. The data thus are not suitable for this 
type of analysis.
A main finding of the present study is the clear effect 
on the growth and concentrate feed conversion ratio, and 
that the effect is present in not only the medically treated 
and untreated group, but also when pooling all animals 
from the outbreak year compared to the next. The latter 
finding indicates that the outbreak affected a far larger 
group of animals than just those deemed to be in need of 
medical treatment.
Growth rate is amongst the most important factors for 
the profitability of rearing of cattle as it determines the 
slaughter weight and feed costs [32, 33]. Reduced feed 
conversion obviously represents an economic loss per se, 
and will exacerbate the negative effect of reduced growth 
rate when present at the same time.
The significant and quick drop in body weight seen 
in many animals during the outbreak occurred with no 
corresponding drop in concentrate consumption, not 
even in the treated bulls. This indicates that the drop was 
caused by a reduced intake of roughage and/or water in 
the initial phase of disease and that even sick bulls man-
age to finish their concentrate. It is significant in the 
sense that sick cattle usually have a decreased appetite, so 
that a normal concentrate feed consumption may falsely 
be interpreted as a sign of good health unless one also 
considers other observations.
Except for a 3-week period of the outbreak, the total 
amount of roughage consumed in the present population 
was reported to be as normal.
The findings emphasize the economic significance of 
BRSV infection. As an illustration of the clinical signifi-
cance of the differences concerning the AAW variable, 
a bull with an AAW of 1.20 at 300 days of age would be 
30 kg heavier than a bull of the same age with an AAW of 
1.10. At 150 days, the same AAW difference corresponds 
to 15  kg. Similarly, a reduced daily weight gain from 
1255 to 1144 g (Table 4), will over 8 months amount to 
23 extra days needed for the more slowly growing bull to 
reach the same weight. For similar rearing systems, these 
numbers may be multiplied with the economic figures 
Fig. 4 Weight to age ratio in two groups of bulls, year versus year comparison. Comparison of bulls without a diagnosis of respiratory disease moni-
tored in the test centre during 2011 (Year 1) versus 2012 (Year 2). Respiratory disease outbreak date in 2011 is denoted by vertical line
Table 4 Average daily weight gain (ADG) and  ADG/
amount of  concentrate consumed in  respiratory disease 
outbreak year versus following year
* P < 0.05
ADG ADG
1000 g concentrate consumed
Following year (n = 177) 1255 423
Outbreak year (n = 128) 1144 345
Difference 111* 78*
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appropriate for a specific country or industry, to produce 
cost estimates.
Some considerations of factors associated with the 
studied herd are important for interpreting the results 
correctly. At any moment there are animals of different 
ages and weights being housed in different areas through-
out the building. Furthermore, removal of older and 
introduction of new bulls occurs regularly. Finally, there 
is a possible effect of season as longitudinal fluctuations 
occur in ambient temperature, roughage quality, staff 
composition, and stocking density. In the present study 
it was attempted to control for such factors, firstly by 
ensuring equal age distribution between the groups com-
pared. Furthermore, when comparing bulls that had been 
housed at different times of the year, the comparison was 
made by using year as the grouping variable, ensuring 
that any seasonal influence would be similar across the 
two groups. However, the herd composition was not fully 
comparable from 2011 to 2012, or the graphs in e.g. Fig. 3 
would have been more congruent and eventually differed 
only in level. Early 2011 had an influx of an unusual large 
group of young test bulls. A full adjustment for age differ-
ences was not possible and this may have influenced the 
statistics for the first part of the year. However, in the fol-
lowing months this effect fades as the curves attain simi-
lar shapes.
The research herd stocked animals of the same sex and 
of the same breed inside the same building where they 
were fed the same diet. The recording of weights and 
feedings were automated, thus likely to have provided 
consistent, comparable and precise data. The animals 
were also monitored by the same stockmen and veteri-
nary surgeons. Thus, the disease cases are similarly likely 
to have been assessed and treated in a consistent manner 
from case to case. These conditions made the herd excep-
tionally well suited for a scientific study, i.e. standardized 
to a degree difficult to find in other herds.
To provide even more robust comparisons, it would 
have been preferable to use more years than just one 
for comparison with the outbreak year. Preceding years, 
e.g. 2010 were considered, but these years were also 
problem years with high frequency of respiratory dis-
ease cases, which was in fact the reason why the initial 
research project was started. Those years may not have 
made a meaningful contrast and were therefore aban-
doned. Even earlier years were not readily available from 
the test centre’s recording system and shortly after 2012, 
weight gain was no longer one of the phenotypic test 
variables. The quality control of this variable was then 
less rigorous and it would consequently not be as suit-
able for analysis. However, the value of adding several 
seasons of comparisons also has its limits. Pooling too 
many years would tend to compound a lot of variation 
from many sources into an average that may or may not 
represent a good base for comparisons. Our comparison 
year has a well-documented health status and is close to 
the outbreak year, which ensures that herd level factors 
have had less time to change. The true size of the effect 
of the outbreak in the study herd is arguably underesti-
mated by our analyses. The higher number of deaths in 
the outbreak year compared to the control year is one 
cause. These cases could obviously not be fully included 
in analyses or graphs, but had they lived, their data would 
undoubtedly have emphasized the poor performance of 
their group. Furthermore, the available bull level disease 
information was in the form of a dichotomous treatment 
variable, which certainly will classify the sickest animals 
correctly but probably missed some bulls with milder 
clinical signs. Nevertheless, these bulls may also show 
decreased performance parameters. On the other hand, 
genetic progress would in itself contribute to higher per-
formance the next year, which produces an opposite esti-
mation bias. However, the increase in growth rate in this 
cattle population is well documented and amounts to a 
reduction of 1 day in a bull’s time to slaughter [34], which 
is on a lower order of magnitude than the differences 
found in the present study and therefore not very impor-
tant to the discussion.
The absolute values of performance parameters such as 
growth rate, weight, and feed conversion are influenced 
by management, breed, feeding as well as numerous other 
factors that may be particular to the research herd. Many 
of those specific factors can probably be summarised as 
better than average management, housing, feeding and 
health care, all contributing to less severe consequences 
of airway infection than in commercial herds. Thus, the 
exact numbers do not necessarily apply directly under 
other circumstances, but the general trends in the results 
as well as the findings of differences between groups in 
the present study have a higher degree of validity and 
should be generally applicable.
Conclusions
The present study shows that intra-herd comparison of 
health and production data can be a valuable approach 
to estimate the costs associated with reduced health sta-
tus. More specifically, the study shows that BRSV affects 
the growth performance of bulls for several months after 
infection. The effect is most pronounced in animals that 
are seriously affected during infection, but a significant 
loss of performance can also be detected in animals 
showing mild or no signs of disease, and despite apparent 
recovery. This amounts to a significant part of the costs 
associated with BRSV, however they may easily be under-
estimated. Such losses are of great concern to the farmer 
and must be taken into account in any cost-benefit 
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analysis of preventive measures towards BRSV infection, 
whether on herd or population level.
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